A clear sign of TGA drivers, page-3

As a successful commercial opportunity, Viraleze is pretty much dead and buried. The failed post-market trial (for hose already with Covid) sealed its fate IMO. An unfortunate own-goal.

So because of the failed trial to reduce viral load in patients with Covid, and until there is in-human clinical evidence to prove that it prevents Covid, how can this product ever become a success? It can’t IMO.

Starpharna would have spent around $10m getting this loss-making product to market, and in doing so have spent 10s of thousands of staff hours distracting the company from its primary reason for existing. And that is developing DEP drugs.